πŸ‡ΊπŸ‡Έ FDA
Patent

US 8207142

Inhibitor of DNA methylation

granted A61KA61K31/513A61K31/7068

Quick answer

US patent 8207142 (Inhibitor of DNA methylation) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/513, A61K31/7068, A61K31/7072, A61K31/7088